James Bunker, MD
Dermatology · McCook, NENPI 1487649869
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $968 of the $1,175 with a category attached, or 82.4%. 8 manufacturers reported payments, led by Lilly USA, LLC at 37.0% of the total. Reporting peaked in 2021 at $301 and has fallen 93.1% since, to $21 in 2024. That places this record below the midpoint for dermatology clinicians in NE, where the typical reported total is $2,089.
Across 59 payments — averaging $19.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$435
- Johnson & Johnson$347
- AbbVie$191
- Novartis$99
- Janssen Scientific Affairs, LLC$49
- Pfizer$23
- plus $30 from 2 others
What the payments were for
- Food & beverage$96882%
- Education$20718%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 28 | $435 |
| Johnson & Johnson | 11 | $347 |
| AbbVie | 11 | $191 |
| Novartis | 5 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $49 |
| Pfizer | 1 | $23 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $14 |
How this compares
$1,175 in reported general payments places this provider in the 40th percentile of 68 dermatology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 12 | $39,924 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 132 | $3,360 |
| Ampicillin Trihydrate | 69 | $2,612 |
| MethotrexateMethotrexate Sodium | 68 | $2,381 |
| Fluorouracil | 24 | $2,105 |
| Clobetasol Propionate | 28 | $1,528 |
| Minocycline Hcl | 35 | $967 |
| Doxycycline Hyclate | 17 | $822 |
| Betamethasone Dipropionate | 18 | $716 |
| Triamcinolone Acetonide | 57 | $691 |
| Ketoconazole | 31 | $568 |
| Mometasone Furoate | 24 | $528 |
| ValacyclovirValacyclovir Hcl | 23 | $497 |
| Hydrocortisone | 51 | $297 |
| Hydroxychloroquine Sulfate | 12 | $268 |
Paid to pharmacies, not to this prescriber.
Other dermatology in McCook
- Rachel PersonOmaha$98K
- Erin BarrettOmaha$96K
- Joel SchlessingerOmaha$89K
- Casey BowenLincoln$51K
- Mathew DaveyOmaha$35K
- Rex LargenLincoln$26K
- Lauren StephensLincoln$18K
- Chad HillyerElkhorn$15K
- Gage RenschOmaha$11K
- Gina WeirLincoln$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.